AIVALS

CARRARA M&A Diagnostic powered by AIVALS™ gives advisors, investors, and brand owners a fast, credible valuation benchmark, built on one of the industry's most comprehensive beauty and wellness transaction databases.

How it works

AIVALS™ combines proprietary transaction intelligence and quantitative AI modelling to estimate valuation multiples for beauty and wellness companies. The model explains approximately 94% of historical transaction multiple variation and predicts observed EV/Sales multiples with an average error of approximately 0.6x, providing a robust benchmark for valuation assessment, M&A readiness and strategic planning. Built on ~1,300 transactions and validated on ~400 cases.

What you get

The model is highly effective at explaining market valuation behavior and provides a robust directional estimate of transaction multiples. An overall report on your business situation, drivers, gap, potential buyers and top three interventions to improve the business value for free. And, a benchmark valuation range for your company or target, positioned against comparable real transactions in beauty, fragrance, and wellness - not generic public-market multiples that don't reflect how this sector actually trades - against a fee.

Who it's for

The application is designed to help brand owners, management teams, investors, and financial institutions assess the potential valuation of beauty and wellness companies with greater insight and consistency.

Where this fits

AIVALS™ is part of our Exit — Valuation & Transaction Intelligence practice — the fast diagnostic that tells you where you stand before you commit to a full valuation, transaction process, or ongoing portfolio monitoring.